Vedolizumab Clearance as a Surrogate Marker for Remission in Inflammatory Bowel Disease Patients: Insights from Real-World Pharmacokinetics.
Saved in:
| Title: | Vedolizumab Clearance as a Surrogate Marker for Remission in Inflammatory Bowel Disease Patients: Insights from Real-World Pharmacokinetics. |
|---|---|
| Authors: | Marković, Srđan1,2 (AUTHOR), Kralj, Đorđe1 (AUTHOR), Svorcan, Petar1,2 (AUTHOR), Knežević Ivanovski, Tamara1 (AUTHOR), Odanović, Olga1 (AUTHOR), Obradović, Sanja3 (AUTHOR), Homšek, Ana4 (AUTHOR), Jovanović, Marija4 (AUTHOR), Savić, Rada5 (AUTHOR), Vučićević, Katarina M.4 (AUTHOR) katarina.vucicevic@pharmacy.bg.ac.rs |
| Source: | Pharmaceutics. Dec2024, Vol. 16 Issue 12, p1629. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
